European Society for Medical Oncology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

European Society for Medical Oncology
Jul 20, 2024, 01:27 | Blog
A novel MDM2/p53 inhibitor in patients with advanced solid tumors - ESMO Open
ESMO Open (The Open Access journal of European Society for Medical Oncology) shared a post…
Jul 19, 2024, 08:42 | Blog
Breaking Science in Gastrointestinal Cancers with Maximiliano Gelli - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "For ESMO members:…
Jul 18, 2024, 22:37 | Blog
ESMO Living Guideline on Oncogene-Addicted Metastatic NSCLC
European Society for Medical Oncology (ESMO) shared a post on LinkedIn: ''The new ESMO Living…
Jul 18, 2024, 15:20 | Drugs
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Agenus shared on LinkedIn: "Today, we announced the outcomes of our End-of-Phase 2 meeting and…
Jul 17, 2024, 21:42 | Blog
Svetlana Nikic: How IVDR is affecting cancer research
Svetlana Nikic shared a post by Evandro de Azambuja, President of BSMO (The Belgian Society of…
Jul 17, 2024, 09:44 | Societies
7 interviews summarizing study results from ESMOGI24
The European Society for Medical Oncology (ESMO) shared on LinkedIn: "The Breaking Science in Gastrointestinal…
Jul 16, 2024, 05:27 | Insight
Newly published ESMO Recommendations on genomics test results for Solid Cancers
ESMO - European Society for Medical Oncology shared on LinkedIn: "How to interpret genomic testing…
Jul 15, 2024, 14:31 | Drugs
Lazar Popovic: ESMO project that will potentially influential oncology drug availability worldwide
Lazar Popovic, Professor of Oncology at the Oncology Institute of Vojvodina, shared on X: "I…
Jul 11, 2024, 14:45 | Blog
Let's board the Train to ESMO to Barcelona - ESMO4Climate
ESMO (European Society for Medical Oncology) shared a post on LinkedIn: ''ESMO4Climate: ESMO encourages delegates…
Jul 10, 2024, 03:24 | Blog
Petra Thaller: Discover the profound benefits of Physical Activity and Outdoor Sports
Petra Thaller, President at Outdoor against cancer, shared on LinkedIn: "OAC Outdoor Against Cancer led…
Jul 7, 2024, 18:32 | Blog
A significant perception gap between patients with Colorectal Cancer and Healthcare Professionals - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: . "A recent…
Jul 7, 2024, 06:28 | Blog
Submit your abstract or TiP by 16 July for ESMOASIA24
ESMO (European Society for Medical Oncology) shared a post on LinkedIn: "Be at the forefront…
Jul 7, 2024, 05:25 | Blog
Submit your abstracts to EMUC24 - European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “It's time to submit your…
Jun 29, 2024, 02:57 | Blog
Komal Jhaveri on antibody-drug conjugates in metastatic breast cancer - ESMO
ESMO shared a post on LinkedIn: “For European Society for Medical Oncology (ESMO) members: Breaking Science…
Jun 28, 2024, 15:58 | Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 | Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:15 | Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 13:09 | Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 | Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 28, 2024, 11:43 | Blog
Mafalda Oliveira discusses ESR1m ctDNA in MBC patients treated by camizestrant
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “For ESMO members: Breaking Science…
Jun 28, 2024, 11:02 | Blog
Severine Guiu explains triple combination therapy for ER+/HER2- ABC with HRR deficiency or MSI - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn:     . “For ESMO members:…
Jun 25, 2024, 03:43 | Insight
The potential of precision medicine in gynaecologic cancers - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: "ESMOGynae24: The combination of comprehensive…
Jun 24, 2024, 11:44 | Insight
Six-year outcomes from EURACAN - ESMO
European Society for Medical Oncology shared a post on LinkedIn: "ESMOGynae24: Six-year outcomes from EURACAN…
Jun 23, 2024, 10:53 | Blog
Breaking Science in Breast Cancer with Hope Rugo - ESMO
ESMO shared a post on LinkedIn: "For ESMO members: Breaking Science in Breast Cancer. Hope Rugo…
Jun 22, 2024, 14:40 | Blog
ESMO welcomes the EU Council Recommendation on Vaccine-Preventable Cancers
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "ESMO welcomes today’s…
Jun 21, 2024, 12:43 | Insight
The new ESMO Clinical Practice Guideline is now available
European Society for Medical Oncology (ESMO) shared on LinkedIn:  “The new ESMO Clinical Practice Guideline…
Jun 20, 2024, 16:05 | Insight
Eliz Tazimova: Our project at ESMO In Focus Breast Cancer 2024 Bulgaria
Eliz Tazimova, COO at Institute for Research of Breast Cancer Treatment, shared a post on…
Jun 19, 2024, 01:47 | Blog
ESO Congratulate Barbara Jereczek-Fossa and Giuseppe Curigliano On Being Elected Presidents of ESTRO and ESMO
European School of Oncology (ESO) shared a post on LinkedIn:      . “The European School of…
Jun 18, 2024, 23:25 | Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 18, 2024, 18:00 | Insight
Elene Mariamidze: The ESMO reunion in Tbilisi, Georgia
Elene Mariamidze, Medical/Clinical Oncologist at Todua Clinic, shared the following post on X: “The ESMO…
Jun 16, 2024, 13:27 | Insight
Join the 9th IARC- ESMO webinar - IARC
International Agency for Research on Cancer (IARC) shared on X: “What is the current status…
Jun 15, 2024, 16:02 | Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 12, 2024, 15:37 | Societies
Giuseppe Curigliano has been appointed as the President Elect of ESMO
The European Society for Medical Oncology (ESMO) has announced the results of its presidential election.…
Jun 7, 2024, 08:45 | Insight
New EHA–ESMO Clinical Practice Guideline for primary CNS Lymphoma
ESMO shared a post on LinkedIn:         . "New Primary Central Nervous System…
Jun 3, 2024, 22:53 | Insight
Paul Healy: AstraZeneca and Daiichi Sankyo have announced positive results from datopotamab deruxtecan in certain lung cancer patients
Paul Healy, Director of PHARMeMED, shared on LinkedIn: "AstraZeneca (AZ) and Daiichi Sankyo have announced positive…
Jun 3, 2024, 22:06 | Blog
A wealth of new data in oncology awaits you in Barcelona - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: ''ESMO24: Exciting News…
May 25, 2024, 07:41 | Insight
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections!
Paolo Tarantino shared on LinkedIn: “I’m extremely excited to support Giuseppe Curigliano for the next…
May 23, 2024, 13:10 | Societies
Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma - ESMO
ESMO – European Society for Medical Oncology posted on LinkedIn: “Updated Renal Cell Carcinoma: ESMO…
May 21, 2024, 10:00 | Blog
Erika Hamilton: Thanks to all who attended ESMO Breast24 and made it such a success
Erika Hamilton shared a post on LinkedIn: ''Thanks to all who attended ESMO Breast24 and…
May 18, 2024, 03:08 | Blog
AI in Breast Cancer management is revolutionising the field - ESMO
ESMO shared a post on LinkedIn: "The rapid integration of Artificial Intelligence  in Breast Cancer…
May 18, 2024, 01:30 | Blog
Eva Schumacher-Wulf: Best poster prize at ESMOBreast24!
Eva Schumacher-Wulf, Editor-in-Chief of Mamma Mia! Magazine, shared on X: "More than proud about the…
May 13, 2024, 12:54 | Blog
Become part of the conversation about the science presented at ESMO Breast24
European Society for Medical Oncology shared on their X page: "Do not miss the latest…
May 12, 2024, 14:34 | Societies
Tom Powles talks to Amanda Psyrri about immune cell-related biomarkers in HNSCC - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: “Latest podcast Annals of Oncology…
May 12, 2024, 12:13 | Insight
Herbert Loong: 6 versus 3 years of adjuvant imatinib in high risk GISTs by Jean-Yves Blay et al.
Herbert Loong shared on LinkedIn: “Congrats Jean-Yves Blay and colleagues of French Sarcoma Group for completing…
May 7, 2024, 05:04 | Blog
Aruni Ghose: United Kingdom’s First Real World Evidence of Sacituzumab Govitecan in mTNBC
Aruni Ghose, Editorial Board Member at BMC, shared a post on LinkedIn: "My favourite Registrar Mentor…
May 5, 2024, 04:18 | Blog
Erman Akkus summaries Merkel-cell carcinoma guideline of ESMO and EURACAN
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X/Twitter: "Merkel-cell…
May 5, 2024, 00:40 | Blog
Martin Harutyunyan: ESMO Preceptorship course on Supportive and Palliative Care
Martin Harutyunyan, Medical Oncologist at the Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Mar 26, 2024, 19:04 | Societies
Federica Giugliano: I am happy to be awarded by ESMO with a merit travel grant to attend ESMO Breast Cancer 2024 in Berlin
Federica Giugliano, Research Fellow at Gustave Roussy Institute, shared on LinkedIn: “I am happy to…
Mar 16, 2024, 10:49 | Blog
Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, recently shared on…
Mar 3, 2024, 17:30 | Insight
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn: "I want to…
Feb 24, 2024, 10:59 | Societies
Bishal Gyawali: We had a very lively JSMO and ESMO joint symposium
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "We…
Feb 11, 2024, 14:41 | Blog
Maria Babak: ESMO Advanced Course on Early Drug Development in Hong Kong was an incredible experience
Maria Babak, Assistant Professor at City University of Hong Kong, shared on LinkedIn: “Bridging the…
Dec 30, 2023, 18:19 | Blog
Vivek Subbiah: Delighted to unwrap our small Precision Medicine present
Vivek Subbiah recently shared on LinkedIn: “Exciting Christmas Eve news! Just published in ESMO -…
Nov 11, 2023, 12:49 | Blog
Benedikt Westphalen: CUPISCO is out in ESMO Open
Benedikt Westphalen, Medical Lead of Precision Oncology at the Cancer Center Munich, shared on LinkedIn:…
All: 256 Posts: 201 - 300
Special Coverage